Abiraterone Acetate tablets（II）
Sponsors
Jiangsu HengRui Medicine Co., Ltd.
Conditions
Prostate Cancer
Phase 1
A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancer
RecruitingNCT06568094
Start: 2024-09-25End: 2027-06-30Target: 100Updated: 2025-12-31
A Study for the Treatment of Metastatic Prostate Cancer With HRS-1167 Tablets Combined With Abiraterone Acetate Tablets and Prednisone
RecruitingNCT06689163
Start: 2024-12-11End: 2026-12-31Target: 66Updated: 2025-09-03